ArticleBMJ open2023

Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial.

Hideaki Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.